118 related articles for article (PubMed ID: 32536234)
1. MicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients.
Rashed RA; Hassan NM; Hussein MM
Leuk Lymphoma; 2020 Oct; 61(10):2475-2481. PubMed ID: 32536234
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
[TBL] [Abstract][Full Text] [Related]
3. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
[TBL] [Abstract][Full Text] [Related]
4. Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.
Elhamamsy AR; El Sharkawy MS; Zanaty AF; Mahrous MA; Mohamed AE; Abushaaban EA
Int J Mol Cell Med; 2017; 6(2):77-86. PubMed ID: 28890884
[TBL] [Abstract][Full Text] [Related]
5. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of miR-96 in patients with acute myeloid leukemia.
Zhao J; Lu Q; Zhu J; Fu J; Chen YX
Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958
[TBL] [Abstract][Full Text] [Related]
7. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.
Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM
Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758
[TBL] [Abstract][Full Text] [Related]
11. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.
Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J
Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040
[TBL] [Abstract][Full Text] [Related]
12. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of miR-92a in patients with gastric cancer.
Ren C; Wang W; Han C; Chen H; Fu D; Luo Y; Yao H; Wang D; Ma L; Zhou L; Han D; Shen M
Tumour Biol; 2016 Jul; 37(7):9483-91. PubMed ID: 26790436
[TBL] [Abstract][Full Text] [Related]
15. [The value of serum microRNA-92a and microRNA-146a levels combined with pulmonary ultrasound score in predicting the severity and prognosis of acute respiratory distress syndrome].
Yu Y; Liu Z; Liao H; He Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1231-1235. PubMed ID: 33198870
[TBL] [Abstract][Full Text] [Related]
16. Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.
Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G
Biomark Med; 2015; 9(5):453-60. PubMed ID: 25620533
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
Zhang P; Sun D; Sun X; Li H
Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
[TBL] [Abstract][Full Text] [Related]
18. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
[TBL] [Abstract][Full Text] [Related]
20. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
Weng H; Lal K; Yang FF; Chen J
Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]